首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >NEUROPROTECTIVE POTENTIAL OF AZADIRACHTA INDICA LEAVES IN DIABETIC RATS
【24h】

NEUROPROTECTIVE POTENTIAL OF AZADIRACHTA INDICA LEAVES IN DIABETIC RATS

机译:糖尿病大鼠叠氮梓叶的神经保护潜力

获取原文
           

摘要

Objective: Azadirachta indica is a treasure of multiple pharmacological properties and presently leaves of this plant have been explored to evaluate the neuroprotective potential in diabetic rats. Methods: Male Sprague-Dawley rats were injected with single intra peritoneal dose of streptozotocin (60mg/ Kg body weight (BW.) to develop animal model of diabetes. Post twenty one days of streptozotocin induction, animals were treated with aqueous Azadirachta indica Leaf Extract (ALE, 600mg/Kg BW.) for seven consecutive days. Followed this, all animals were evaluated for the levels of blood glucose, lipid peroxidation (LPO), C Reactive Proteins (CRP), pro oxidant biomarkers and histological changes. Results: Streptozotocin treated rats exhibited elevated levels of blood glucose, LPO, CRP and altered pro oxidant biomarkers in comparison to control rats. Additionally, histological alterations/damage was evidenced as fragmentation, vacuolization, inflammation etc. However, ALE treatment to these rats significantly decreased blood glucose levels, LPO, CRP levels and restored pro-oxidants status. Light microscopic and ultra microscopic analysis also indicated less damage, tissue architectural changes in comparison to untreated diabetic rats. Further decrease in hyperalgesia and inflammation levels; along with protective and restorative changes following ALE treatment suggested the neuroprotective potential of Azadirachta indica leaves in diabetic rats. Conclusion: The oral administration of ALE to streptozotocin induced diabetic animals resulted in neuro-protection against degenerative oxidative stress associated with metabolic and histopathological damage in the brain. Key words: Azadirachta indica , Antioxidants, Hyperalgesia, Neuroprotection.
机译:目的:印za是具有多种药理特性的宝藏,目前已探索该植物的叶子以评估糖尿病大鼠的神经保护能力。方法:雄性Sprague-Dawley大鼠腹腔内注射单剂量链脲佐菌素(60mg / Kg体重)以建立糖尿病动物模型,在链脲佐菌素诱导第21天后,用印za叶水提取物处理动物。 (ALE,600mg / Kg BW。)连续7天,随后评估所有动物的血糖,脂质过氧化(LPO),C反应蛋白(CRP),促氧化剂生物标志物和组织学变化。与对照大鼠相比,链脲佐菌素治疗的大鼠血糖,LPO,CRP水平升高,促氧化剂生物标志物改变,此外,组织学改变/损伤表现为破碎,空泡,炎症等。葡萄糖水平,LPO,CRP水平和恢复的前氧化剂状态。光学显微镜和超显微分析也表明损伤较小,组织构筑物与未治疗的糖尿病大鼠相比,血清变化明显。痛觉过敏和炎症水平的进一步降低; ALE处理后的保护性和恢复性变化表明,印A叶对糖尿病大鼠具有神经保护作用。结论:对链脲佐菌素诱导的糖尿病动物口服ALE可以对与大脑代谢和组织病理学损害相关的变性氧化应激产生神经保护作用。关键词:印度印A,抗氧化剂,痛觉过敏,神经保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号